https://markets.businessinsider.com/news/stocks/humacyte-announces-long-term-safety-efficacy-results-of-symvess-1035665630
Humacyte announces long-term safety, efficacy results of Symvess | Markets Insider
Humacyte (HUMA) announced the publication of new, long-term data assessing the durability of Symvess in extremity arterial trauma patients in th...
long termefficacy resultsannouncessafety